Beranda › Purpura Trombositopenik Idiopatik › North Carolina › Greenville
Uji klinis Purpura Trombositopenik Idiopatik di Greenville, NC
6 studi untuk Purpura Trombositopenik Idiopatik mencari peserta di lokasi sekitar Greenville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- East Carolina University, Greenville
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Menerima pesertaFase 2
- East Carolina University, Greenville
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Menerima pesertaFase 3
- East Carolina University, Greenville
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- East Carolina University, Greenville
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Menerima pesertaFase 2
- East Carolina University, Greenville
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- Brody School of Medicine at East Carolina University, Greenville
Uji klinis Purpura Trombositopenik Idiopatik di kota lain
- Los Angeles, CA7 studi
- Washington, DC6 studi
- Boston, MA6 studi
- The Bronx, NY5 studi
- Durham, NC4 studi
- Rochester, MN4 studi
- Seattle, WA4 studi
- Houston, TX4 studi
- Portland, OR4 studi
- New Orleans, LA3 studi
- Cedar Rapids, IA3 studi
- Cleveland, OH3 studi
Studi lain di Greenville
- Leukemia Mieloid Akut10 studi
- Penyakit Sel Sabit9 studi
- Gagal Jantung6 studi
- Leukemia Limfositik Kronis5 studi
- Limfoma Burkitt5 studi
- Obesitas5 studi
- Diabetes Tipe 25 studi
- Gangguan Darah5 studi
- Kanker (semua jenis)4 studi
- Penyakit Autoimun4 studi
- Neoplasma Mieloproliferatif4 studi
- Sindrom Mielodisplastik4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.